NCT00225394View on ClinicalTrials.gov

Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

July 31, 2006

Conditions
CMV DiseaseViral ResistanceRejectionDeath
Trial Locations (4)

02215

Beth Israel Deaconess Medical Center, Boston

01803

Lahey Clinic Transplant, Burlington

01655

UMass Memorial Medical Center, Worcester

02903

Rhode Island Hospital, Providence

Sponsors

Collaborators (1)

Lahey Clinic
All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Lahey Clinic

OTHER

collaborator

Rhode Island Hospital

OTHER

lead

University of Massachusetts, Worcester

OTHER